Key result
Novel KCNH2 p.R397C mutation in Brugada syndrome increases IKr density and potentially shortens action potentials.
Why the study?
In patients with Brugada syndrome, mutations in responsible genes other than SCN5A remain poorly elucidated.
Does the KCNH2 c.1189C>T (p.R397C) mutation alter I(Kr) density and action potential duration in Brugada syndrome?
Case Report (n=1)
Does the KCNH2 c.1189C>T (p.R397C) mutation alter I(Kr) density and action potential duration in Brugada syndrome?
A novel gain-of-function mutation in KCNH2 (p.R397C) increases I(Kr) density and may shorten the cardiac action potential, contributing to the Brugada syndrome phenotype.
Should not change Brugada management; leaves open KCNH2 gain-of-function contribution pending human validation.
Brugada syndrome (BrS) is an inherited disease characterized by right precordial ST-segment elevation on electrocardiograms (ECGs), and a high risk of life-threatening ventricular arrhyth-mia and sudden cardiac death. In BrS patients, except for SCN5A, mutations in other responsible genes are poorly elucidated. We identified a new missense mutation, c.1189C>T (p.R397C), in the KCNH2 gene in asymptomatic male proband with diagnosed BrS. We performed patch-clamp analysis on I(Kr) reconstituted with this KCNH2 mutation in Chinese hamster ovary cells and compared the phenotype with the wild type. We found that the R397C mutation increased the I(Kr) density. In silico modeling demonstrated that this missense mutation potentially leads to the shortening of action potential in the heart.
No takes yet. Share an insight, caveat, or question.
Abramochkin et al. (2023) conducted a case report in Brugada Syndrome (n=1). KCNH2 c.1189C>T (p.R397C) mutation vs. Wild type was evaluated on I(Kr) density and action potential duration. A novel KCNH2 missense mutation (p.R397C) identified in a Brugada syndrome patient increased I(Kr) density in vitro and potentially shortens the cardiac action potential in silico.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: